These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17011389)

  • 1. When to use antimuscarinics in men who have lower urinary tract symptoms.
    Lee JY; Kim DK; Chancellor MB
    Urol Clin North Am; 2006 Nov; 33(4):531-7, x. PubMed ID: 17011389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia.
    Chapple C
    Curr Opin Urol; 2010 Jan; 20(1):43-8. PubMed ID: 19875964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.
    Athanasopoulos A; Chapple C; Fowler C; Gratzke C; Kaplan S; Stief C; Tubaro A
    Eur Urol; 2011 Jul; 60(1):94-105. PubMed ID: 21497434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical management of lower urinary tract symptoms with combined medical therapy.
    Roehrborn CG
    BJU Int; 2008 Nov; 102 Suppl 2():13-7. PubMed ID: 19032605
    [No Abstract]   [Full Text] [Related]  

  • 5. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.
    Chapple CR; Roehrborn CG
    Eur Urol; 2006 Apr; 49(4):651-8. PubMed ID: 16530611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of anticholinergic therapy in men.
    Bauer R; Kaufman R; Mian BM
    Can J Urol; 2008 Dec; 15(6):4359-62. PubMed ID: 19046488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of overactive bladder in patients with benign prostatic hyperplasia in the Czech Republic.
    Hanuš T; Zámečník L; Doležal T; Karmazínová Z
    Urol Int; 2011; 86(4):407-13. PubMed ID: 21454947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Chapple C; Herschorn S; Abrams P; Sun F; Brodsky M; Guan Z
    Eur Urol; 2009 Sep; 56(3):534-41. PubMed ID: 19070418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimuscarinics and bladder outlet obstruction: From a contraindication to an indication?
    Athanasopoulos A
    Neurourol Urodyn; 2010; 29 Suppl 1():S46-50. PubMed ID: 20127792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor antagonists for overactive bladder.
    Abrams P; Andersson KE
    BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Giacomo Novara, Antonio Galfano, Vincenzo Ficarra and Walter Artibani. Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: a systematic review. Eur urol 2006;50:675-83.
    Blake-James BT; Emberton M
    Eur Urol; 2007 Apr; 51(4):1144-5; author reply 1145. PubMed ID: 17113218
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Speakman MJ
    Eur Urol; 2009 Sep; 56(3):542-3. PubMed ID: 19070420
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Dmochowski R
    Eur Urol; 2009 Sep; 56(3):542. PubMed ID: 19070419
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of muscarinic receptor antagonists in the treatment of men with lower urinary tract symptoms secondary to BPH].
    Kaplan SA
    Actas Urol Esp; 2007 Feb; 31(2):86-91. PubMed ID: 17645086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The resolution of detrusor over activity after medical and surgical treatment in patients with bladder outlet obstruction.
    Sriplakich S; Promwatcharanon K
    J Med Assoc Thai; 2007 Nov; 90(11):2326-31. PubMed ID: 18181315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sildenafil citrate on bladder outlet obstruction: a mouse model.
    Beamon CR; Mazar C; Salkini MW; Phull HS; Comiter CV
    BJU Int; 2009 Jul; 104(2):252-6. PubMed ID: 19154466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimuscarinic Use in Men Treated With Bladder Outlet Obstruction Medication Therapy.
    Vouri SM; Strope SA; Olsen MA; Xian H; Schootman M
    Urology; 2018 Dec; 122():76-82. PubMed ID: 30205105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.